Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790199 | Urologic Oncology: Seminars and Original Investigations | 2018 | 6 Pages |
Abstract
PBT is associated with reduced recurrence-free survival, CSS, and OS in patients undergoing nephrectomy for RCC. Worse oncological outcomes are also found in a separate analysis for patients undergoing PN.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yasmin M.D., Med.Msc., Dorit E. M.D., Zohar M.D., Ph.D., Issac M.D., Jacob M.D.,